The gut microbiome plays a significant role in regulating the immune system and metabolic processes, both of which are crucial in cancer development and progression. Dysbiosis, or an imbalance in the gut microbiome, has been linked to various cancers, including colorectal cancer. Researchers are exploring the use of fecal microbiota transplants (FMT) to restore a healthy microbiome in cancer patients, potentially improving treatment outcomes.
